Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alaris Biologic Technologies

2013 FOUNDED
OOB STATUS
11-20 EMPLOYEES
Out of Business LATEST DEAL TYPE
Description

Developer of biologic technologies designed to advance human healing process. The company's biologic technologies offers a selection of human-derived products, soft tissue grafts, bone and birth tissue biologics, enabling biotechnological companies to insure allograft quality and safety.

Formerly Known As
AmnioLife
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 3542 North West 97th Boulevard
  • Gainesville, FL 32606
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Alaris Biologic Technologies’s full profile, request a free trial.

Alaris Biologic Technologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jul-2019 00.000 Completed Out of Business
2. Early Stage VC (Series A) 06-Jan-2016 00000 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) 25-Feb-2015 $833K $833K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Alaris Biologic Technologies Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000 00000000 Formerly PE-Backed Alachua, FL 000 00000 000000000 00000
To view this company’s complete list of competitors, request access »